Call 800-934-1582(Sponsored) to speak with an expert or browse our directory to find meetings organized by location across the country
With the FDA declaring that brand-name supplies of GLP-1 drugs have stabilized, compounded versions are no longer permitted under the shortage exception
Many expect the waiver to be extended given bipartisan support and ongoing provider shortages
Candidacy is determined at your consultation after we review your history, medications, and lab work
The increased fat loss is just an extra benefit for me, but to each their own
Without an active shortage declaration, compounded formulations that are essentially copies of FDA-approved drugs are presumptively unlawful, and the FDA has made clear that affordability, convenience, or patient preference are insufficient justifications on their own